Wilmington Savings Fund Society FSB Has $4.83 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Wilmington Savings Fund Society FSB lessened its stake in shares of Teleflex Incorporated (NYSE:TFX) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 27,131 shares of the medical technology company’s stock after selling 628 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Teleflex were worth $4,829,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Cromwell Holdings LLC grew its holdings in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares during the last quarter. Avior Wealth Management LLC increased its position in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new position in shares of Teleflex during the third quarter valued at $40,000. True Wealth Design LLC raised its stake in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after acquiring an additional 166 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Teleflex by 131.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on TFX shares. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial cut their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Trading Down 1.4 %

NYSE:TFX opened at $171.13 on Friday. The firm’s 50 day moving average is $180.04 and its 200 day moving average is $211.25. Teleflex Incorporated has a 12 month low of $170.30 and a 12 month high of $256.85. The stock has a market capitalization of $7.95 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.